Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Review of AIDSVAX studies past and present

Dec. 15, 1998

Highly potent anti-HIV betulin derivative acts at a late stage in the viral life cycle

Dec. 14, 1998

Virological and pharmacokinetic profile presented for structurally novel NNRTIs from DuPont

Dec. 14, 1998

Noninfectious HIV particles as immunogens for treating or preventing HIV infection/AIDS

Dec. 11, 1998

Combination tablet that eases pill burden in HIV therapy now available in Canada

Dec. 10, 1998

Orally bioavailable anti-HIV peptides described in patent literature by Japan Energy

Dec. 10, 1998

HHS recommends first PI-sparing AIDS treatment regimen

Dec. 8, 1998

Canadian approval obtained for Serostim

Dec. 4, 1998

New HIV protease inhibitors in development at Monsanto

Dec. 3, 1998

Hydroxyurea-containing salvage regimens for advanced-stage HIV infection

Dec. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....